Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II
about
Regulation of ALK-1 signaling by the nuclear receptor LXRbetaHereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of diseaseHighlights on endoglin (CD105): from basic findings towards clinical applications in human cancerRole of endoglin in fibrosis and sclerodermaContrasting roles of different endoglin forms in atherosclerosisThe role of transforming growth factor β1 in the regulation of blood pressurePotential roles of BMP9 in liver fibrosisEndoglin regulates mural cell adhesion in the circulatory systemEndoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vesselsEndoglin haploinsufficiency promotes fibroblast accumulation during wound healing through Akt activationIdentification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor beta receptor signalingCellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetesEndoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation.Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors.Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse modelsALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migrationPeptide ligands that use a novel binding site to target both TGF-β receptors.Endoglin Mediates Vascular Maturation by Promoting Vascular Smooth Muscle Cell Migration and Spreading.Endoglin in liver fibrogenesis: Bridging basic science and clinical practiceInvestigation of endoglin wild-type and missense mutant protein heterodimerisation using fluorescence microscopy based IF, BiFC and FRET analyses.Structural and functional insights into endoglin ligand recognition and binding.Structural Basis of the Human Endoglin-BMP9 Interaction: Insights into BMP Signaling and HHT1Variation in endoglin pathway genes is associated with preeclampsia: a case-control candidate gene association studyCD105 (endoglin)-negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacitiesAnti-endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculature.Fibrotic response in fibroblasts from congenital disorders of glycosylation.Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growthHereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family.SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-β1 activity.CD105 protein depletion enhances human adipose-derived stromal cell osteogenesis through reduction of transforming growth factor β1 (TGF-β1) signaling.5'UTR mutations of ENG cause hereditary hemorrhagic telangiectasia.Regulation of TGF-β receptor hetero-oligomerization and signaling by endoglin.Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts.Identification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancerDecreased Endoglin expression in the pulmonary vasculature of nitrofen-induced congenital diaphragmatic hernia rat model.Novel biochemical pathways of endoglin in vascular cell physiology.Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathwayPECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesisEndothelium-derived microparticles from chronically thromboembolic pulmonary hypertensive patients facilitate endothelial angiogenesis
P2860
11c58f75041886bd43bbaba03f24c7dd2b568c2e38a4d6b2268b422a907e1ba4a7915f7c59d7b7018354e4cf01499a2f9ab75be803a0a467d00a7f3aa89c2b536120cfa32fd3f943644dbc3eafcb94febae6a717a4a9c9344adc08d2b023f1527be16fb2d07ef6c6c10b9c08ef84cd4c8caa58f9f52991cdd0f9df05e9bc1e8a25e9067c3f080b34c8dfe5bef3856f37e2d5e478671e7c193d4ebfd1abcdb62e
P248
Q24312839-0A93D9C4-90A4-40A3-B167-36DD1209B8F8Q24645017-1F41E6C2-EE00-4C7B-AC78-CB82299F0F67Q24798737-B8FB482E-B17A-4FD0-A98A-8214BE5699BEQ26821836-64BCFFCC-42CB-4508-90B0-BCEC451DB34AQ26995380-18898555-1A27-4D8C-A9CB-9BABE255F640Q26998564-3A25176D-650A-4951-AEBE-209BC64B8C78Q26998823-60C42332-079E-4E06-8C04-BAA0DB294FA2Q27326704-192429B2-0DBD-4F0B-9CB6-45E390ACFBADQ28207513-7F11A0F2-ECEE-4146-A38F-EEBC57B324C5Q28511364-93433513-9608-4D37-A5CB-4F6E4E064D2EQ28575076-B85FA08C-C670-4EC7-B9CD-CC29D2AB46C3Q30419393-BF920C2F-7455-4BF9-B00C-9E0C0733E4B0Q30480194-EDA4006E-BB0A-43B6-94B4-B3890DEEC57AQ31126839-E481D689-2109-4603-B6D3-05787EE9115FQ33640207-3F959C11-31AA-4D22-B5A1-FFA630BD886BQ33705264-A0AF8121-A21E-4F09-9AFE-4DFC744D2D7AQ33708971-B95A919F-CF46-408B-B87B-4468A7D2E94DQ33727308-B12B746C-E61F-4358-A849-6F8AF171A0D1Q33728841-CD303E9C-1496-4CC9-9FC5-8638E4CE2EE5Q33981941-63BBEFE6-E9D6-47FB-AE99-E6AB202295E7Q34162465-E21574A0-BB47-4C59-9956-2519620372ABQ34557333-964481D7-34AD-48D9-8976-58ABF7F31CFEQ34645404-A703D1F5-34B4-4686-A8FD-1C5C68E4F1A8Q35017103-C04FAF3C-4799-427C-89BF-1053B50218B4Q35201283-9BC429DF-ED24-401C-9DAD-4605B78E6909Q35216162-89B6F47B-A2C7-4041-A85D-63CC6C8875F2Q35314203-FCBD940B-FC48-4225-90C7-066E7344E772Q35443250-B2010BD4-8D4B-4BF8-AFE7-3B092E598F02Q35550184-A93979C7-A85C-49B4-A60E-2EDB0B6009A0Q35550776-FD470F10-8717-4589-B8FF-01DE86E2CD2DQ35604414-2E11252C-81C4-4908-8596-1C158EC80D28Q35750778-EA928DE4-23EA-49C6-8817-4136E9C94DA5Q36000743-735EEA61-1FDB-4F60-B8AE-EEDA39DC4BB1Q36054237-DADA3202-5AC7-4F9B-8FDB-965EBE6BDCE2Q36081416-A53F6ECB-1C6E-4585-AE80-8DD09E37FE27Q36185229-4C5EAABD-0CE5-4F1A-B1C5-9276403477E0Q36381160-05530522-53AA-4021-9CC7-5E7930C1CF43Q36440899-1A862BA1-4DFC-41F6-8500-EC0326D61222Q36473318-85456061-D602-403A-A193-9FBE5F40A4F1Q36476019-73F5D594-082A-47BC-B7A5-54F9BAC02361
P2860
Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Extracellular and cytoplasmic ...... factor-beta receptors I and II
@ast
Extracellular and cytoplasmic ...... factor-beta receptors I and II
@en
Extracellular and cytoplasmic ...... factor-beta receptors I and II
@nl
type
label
Extracellular and cytoplasmic ...... factor-beta receptors I and II
@ast
Extracellular and cytoplasmic ...... factor-beta receptors I and II
@en
Extracellular and cytoplasmic ...... factor-beta receptors I and II
@nl
prefLabel
Extracellular and cytoplasmic ...... factor-beta receptors I and II
@ast
Extracellular and cytoplasmic ...... factor-beta receptors I and II
@en
Extracellular and cytoplasmic ...... factor-beta receptors I and II
@nl
P2093
P921
P356
P1476
Extracellular and cytoplasmic ...... factor-beta receptors I and II
@en
P2093
Ainhoa Letamendia
Carmelo Bernabeu
Mercedes Guerrero-Esteo
P304
P356
10.1074/JBC.M111991200
P407
P577
2002-08-09T00:00:00Z